- Bonso Electronics International Inc. (BNSO): Important & Key Factors of Technology Stock
- What's the Analyst Recommendation for PhaseBio Pharmaceuticals Inc. (PHAS)?
- Alliance Resource Partners L.P. (ARLP): Important & Key Factors of Energy Stock
- AeroCentury Corp. (ACY) Plunged -11.39%, Can Traders Take Benefit?
- Pixelworks Inc. (PXLW): Important & Key Factors of Technology Stock
Rodman & Renshaw declared it was Initiated coverage of Marrone Bio Innovations Inc. in a research note on March 16, 2016. The analysts assigned a Buy rating to the stock. Jefferies rated the stock as a Hold in a research noted published on May 20, 2015. Stifel rated the stock as a Buy in a research note published on September 04, 2014.
MBII Recent Trade
The share price of MBII ascended by $0.06 during the exchanging session on 07/15/20 to exchange at $1.13. Marrone Bio Innovations Inc. stock has an exchanging volume of 0.19 million shares, which is low, contrasted with its 3-months average volume of 279.89K shares. Its market capitalization has now reached to $169.31M and analysts have a consensus target price of $1.78 in the 12-month period.
MBII Past Trading Activity
The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, MBII price has rose by 0.44%. In the course of past three months sees the stock go up around 81.31%, while it has gain 7.08% over the past six months and 12.38% since the start of the year.
MBII Earning History
Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Jun 2020), the firm recorded a revenue of 9.65 billion, which was higher than the gauge of 10.38M made by certain experts. For that equivalent quarter, Marrone Bio Innovations Inc. posted -$0.05 earnings per share (EPS) which was underneath the consensus estimate of -$0.03 by -$0.02, which represents to a reduction by -66.70%.
MBII Price Performance
Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Marrone Bio Innovations Inc. has seen its stock exchanging -6.20% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +86.04% above its three-month low. A more extensive look sees MBII exchanging -34.39% beneath its 52-week high and 86.04% above from its 52-week low price.
MBII Instability & Beta Factor
The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 4.29%, while it has a month to month instability of 6.40%. The firm has an ATR (Average True Range) of 0.07 and a beta factor of 0.27.